中国医药
中國醫藥
중국의약
CHINA MEDICINE
2012年
9期
1131-1132
,共2页
梁群英%冯爱菊%张玉文%邱晓娣%窦颖
樑群英%馮愛菊%張玉文%邱曉娣%竇穎
량군영%풍애국%장옥문%구효제%두영
直肠肿瘤%基因,肿瘤%B7-H4%免疫组织化学%预后
直腸腫瘤%基因,腫瘤%B7-H4%免疫組織化學%預後
직장종류%기인,종류%B7-H4%면역조직화학%예후
Rectal neoplasma%Genes,neoplasm%B7-H4%Immunohistochemistry%Prognosis
目的 研究B7-H4基因在直肠癌组织中的表达及其临床意义.方法 采用免疫组织化学SP法检测B7-H4基因分子在65例直肠癌组织中的表达水平.结果 B7-H4基因在直肠癌组织中表达阳性率为78.5%(51/65);B7-H4基因的阳性表达与直肠癌患者的性别、年龄、肿瘤大小无关(P>0.05),而与肿瘤分期和有无淋巴结转移相关(P<0.05);BT-H4基因阳性表达的直肠癌患者平均生存时间明显短于阴性表达患者[(36±7)个月比(48±9)个月,P<0.05].结论 B7-H4基因在直肠癌组织的过表达,可能为直肠癌新的具有诊断价值的肿瘤标志物,可作为直肠癌患者预后不良的参考指标.
目的 研究B7-H4基因在直腸癌組織中的錶達及其臨床意義.方法 採用免疫組織化學SP法檢測B7-H4基因分子在65例直腸癌組織中的錶達水平.結果 B7-H4基因在直腸癌組織中錶達暘性率為78.5%(51/65);B7-H4基因的暘性錶達與直腸癌患者的性彆、年齡、腫瘤大小無關(P>0.05),而與腫瘤分期和有無淋巴結轉移相關(P<0.05);BT-H4基因暘性錶達的直腸癌患者平均生存時間明顯短于陰性錶達患者[(36±7)箇月比(48±9)箇月,P<0.05].結論 B7-H4基因在直腸癌組織的過錶達,可能為直腸癌新的具有診斷價值的腫瘤標誌物,可作為直腸癌患者預後不良的參攷指標.
목적 연구B7-H4기인재직장암조직중적표체급기림상의의.방법 채용면역조직화학SP법검측B7-H4기인분자재65례직장암조직중적표체수평.결과 B7-H4기인재직장암조직중표체양성솔위78.5%(51/65);B7-H4기인적양성표체여직장암환자적성별、년령、종류대소무관(P>0.05),이여종류분기화유무림파결전이상관(P<0.05);BT-H4기인양성표체적직장암환자평균생존시간명현단우음성표체환자[(36±7)개월비(48±9)개월,P<0.05].결론 B7-H4기인재직장암조직적과표체,가능위직장암신적구유진단개치적종류표지물,가작위직장암환자예후불량적삼고지표.
Objective To explore the expression of B7-H4 in rectal carcinoma and the relationship between its expression and the clinicopathological features. Methods The expression of B7-H4 was detected by immunohistochemistry in 65 patients with rectal carcinomas.Results The positive rate of B7-H4 in cases of rectal carcinomas was 78.5% (51/65),which was apparently higher than that of normal rectal mucosa epitheliums(P <0.05 ).The expression of B7-H4 in patients with rectal carcinomas was closely correlated with stage and lymph node metastasis,but was irrelevant to sex,age and tumor size.The mean survival time in patients with positive expression of B7-H4 was significantly shorter than that of cases with negative expression.Conclusion The overexpression of B7-H4 might be involved in the onset and progression of rectal carcinoma and an be a reference index of poor prognosis in rectal carcinoma.